mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
MD

Mangalam Drugs And Organics Limited

NSE:MANGALAMBSE:MANGALAM
HealthcarePharmaceuticals & Biotechnology
₹29.2
-5.17%1 Oct close
Mkt cap
₹46 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&ODocumentsEventsAnnouncementsNotes
ConsolidatedStandalone

Consolidated figures

RatioMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Margins
Gross margin %———33.7%47.4%32.4%
EBITDA margin %15.1%10.9%6.9%4.7%11.3%-6.4%
EBIT margin %12.7%8.6%3.9%0.7%6%-14.3%
PAT margin %7.3%4.4%0.3%-2.5%2.1%-19.1%
Working capital
Receivable days———284563
Inventory days———185303239
Payable days———98199177
NWC days———114149126
Leverage
Current ratio1.231.41.251.071.040.79
Debt to EBITDA11.472.685.062.27—
Debt to equity0.440.480.450.650.541.02
Interest coverage5.23.51.20.21.3-2
Asset turnover1.461.371.041.110.870.74
Return ratios
Return on assets %10.6%6%0.4%-2.7%1.8%-14.1%
Return on capital employed %31.5%22%7.6%1.6%11.4%-22.1%
Return on equity %21.4%13.1%0.8%-6.7%4.5%-43.1%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.